Abbott Laboratories (ABT)
103.44
+1.11
(+1.08%)
USD |
NYSE |
Jul 05, 14:52
Abbott Laboratories SG&A Expense (TTM): 11.15B for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 11.15B |
December 31, 2023 | 10.95B |
September 30, 2023 | 11.20B |
June 30, 2023 | 11.21B |
March 31, 2023 | 11.22B |
December 31, 2022 | 11.25B |
September 30, 2022 | 11.32B |
June 30, 2022 | 11.36B |
March 31, 2022 | 11.33B |
December 31, 2021 | 11.32B |
September 30, 2021 | 10.85B |
June 30, 2021 | 10.38B |
March 31, 2021 | 9.931B |
December 31, 2020 | 9.696B |
September 30, 2020 | 9.539B |
June 30, 2020 | 9.677B |
March 31, 2020 | 9.835B |
December 31, 2019 | 9.765B |
September 30, 2019 | 9.711B |
June 30, 2019 | 9.648B |
March 31, 2019 | 9.68B |
December 31, 2018 | 9.744B |
September 30, 2018 | 9.862B |
June 30, 2018 | 9.60B |
March 31, 2018 | 9.284B |
Date | Value |
---|---|
December 31, 2017 | 9.182B |
September 30, 2017 | 8.378B |
June 30, 2017 | 7.891B |
March 31, 2017 | 7.478B |
December 31, 2016 | 6.736B |
September 30, 2016 | 6.718B |
June 30, 2016 | 6.756B |
March 31, 2016 | 6.746B |
December 31, 2015 | 6.785B |
September 30, 2015 | 6.796B |
June 30, 2015 | 6.725B |
March 31, 2015 | 6.647B |
December 31, 2014 | 6.53B |
September 30, 2014 | 6.405B |
June 30, 2014 | 6.422B |
March 31, 2014 | 6.487B |
December 31, 2013 | 6.653B |
September 30, 2013 | 6.270B |
June 30, 2013 | 6.578B |
March 31, 2013 | 6.678B |
December 31, 2012 | 6.734B |
September 30, 2012 | 3.089B |
June 30, 2012 | 5.408B |
March 31, 2012 | 6.357B |
December 31, 2011 | 7.365B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
9.539B
Minimum
Sep 2020
11.36B
Maximum
Jun 2022
10.62B
Average
10.95B
Median
Dec 2023
SG&A Expense (TTM) Benchmarks
Intuitive Surgical Inc | 1.975B |
ResMed Inc | 915.63M |
Stryker Corp | 7.188B |
Boston Scientific Corp | 5.339B |
Insulet Corp | 771.90M |